Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 305

1.

Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction.

Homer D, Nightingale P, Jobanputra P.

Musculoskeletal Care. 2009 Jun;7(2):78-92. doi: 10.1002/msc.141.

PMID:
18792423
[PubMed - indexed for MEDLINE]
2.

The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.

Aletaha D, Smolen JS.

Rheumatology (Oxford). 2002 Dec;41(12):1367-74.

PMID:
12468815
[PubMed - indexed for MEDLINE]
Free Article
3.

Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.

Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, Porter DR.

Arthritis Rheum. 2008 May;58(5):1310-7. doi: 10.1002/art.23449.

PMID:
18438851
[PubMed - indexed for MEDLINE]
Free Article
4.

An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.

van Roon EN, van den Bemt PM, Jansen TL, Houtman NM, van de Laar MA, Brouwers JR.

Clin Ther. 2009 Aug;31(8):1737-46. doi: 10.1016/j.clinthera.2009.08.009. Review.

PMID:
19808132
[PubMed - indexed for MEDLINE]
5.

Leflunomide treatment in elderly patients with rheumatoid or psoriatic arthritis: retrospective analysis of safety and adherence to treatment.

Alivernini S, Mazzotta D, Zoli A, Ferraccioli G.

Drugs Aging. 2009;26(5):395-402. doi: 10.2165/00002512-200926050-00003.

PMID:
19552491
[PubMed - indexed for MEDLINE]
6.

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.

Kremer JM, Genovese MC, Cannon GW, Caldwell JR, Cush JJ, Furst DE, Luggen ME, Keystone E, Weisman MH, Bensen WM, Kaine JL, Ruderman EM, Coleman P, Curtis DL, Kopp EJ, Kantor SM, Waltuck J, Lindsley HB, Markenson JA, Strand V, Crawford B, Fernando I, Simpson K, Bathon JM.

Ann Intern Med. 2002 Nov 5;137(9):726-33.

PMID:
12416946
[PubMed - indexed for MEDLINE]
7.

Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.

Weaver AL, Lautzenheiser RL, Schiff MH, Gibofsky A, Perruquet JL, Luetkemeyer J, Paulus HE, Xia HA, Leff JA; RADIUS Investigators.

Curr Med Res Opin. 2006 Jan;22(1):185-98.

PMID:
16393444
[PubMed - indexed for MEDLINE]
8.

Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.

Scott DL, Smolen JS, Kalden JR, van de Putte LB, Larsen A, Kvien TK, Schattenkirchner M, Nash P, Oed C, Loew-Friedrich I; European Leflunomide Study Group.

Ann Rheum Dis. 2001 Oct;60(10):913-23.

PMID:
11557646
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.

Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I.

Arthritis Rheum. 2000 Mar;43(3):495-505. Erratum in: Arthritis Rheum 2000 Jun;43(6):1345.

PMID:
10728741
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.

Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.

Arthritis Rheum. 2001 Sep;44(9):1984-92.

PMID:
11592358
[PubMed - indexed for MEDLINE]
Free Article
12.

Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.

Wolfe F, Michaud K, Stephenson B, Doyle J.

J Rheumatol. 2003 Aug;30(8):1725-32.

PMID:
12913927
[PubMed - indexed for MEDLINE]
13.

Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register.

Lie E, van der Heijde D, Uhlig T, Mikkelsen K, Kalstad S, Kaufmann C, Rødevand E, Kvien TK.

Ann Rheum Dis. 2011 Dec;70(12):2103-10. doi: 10.1136/ard.2011.152363. Epub 2011 Aug 28.

PMID:
21875874
[PubMed - indexed for MEDLINE]
14.

Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.

Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, Fox R, Moreland L, Olsen N, Furst D, Caldwell J, Kaine J, Sharp J, Hurley F, Loew-Friedrich I.

Arch Intern Med. 1999 Nov 22;159(21):2542-50.

PMID:
10573044
[PubMed - indexed for MEDLINE]
15.

Disease modification in rheumatoid arthritis with leflunomide.

Emery P.

Scand J Rheumatol Suppl. 1999;112:9-14.

PMID:
10668522
[PubMed - indexed for MEDLINE]
16.

The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.

Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T; FIN-RACo Trial Group.

Arthritis Rheum. 2009 May;60(5):1222-31. doi: 10.1002/art.24447.

PMID:
19404945
[PubMed - indexed for MEDLINE]
Free Article
17.

Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.

van den Bemt BJ, van den Hoogen FH, Benraad B, Hekster YA, van Riel PL, van Lankveld W.

J Rheumatol. 2009 Oct;36(10):2164-70. doi: 10.3899/jrheum.081204. Epub 2009 Sep 1.

PMID:
19723906
[PubMed - indexed for MEDLINE]
18.

Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.

Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Leirisalo-Repo M.

Arthritis Rheum. 2004 Jan;50(1):55-62.

PMID:
14730599
[PubMed - indexed for MEDLINE]
Free Article
19.

Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis.

Calgüneri M, Pay S, Calişkaner Z, Apraş S, Kiraz S, Ertenli I, Cobankara V.

Clin Exp Rheumatol. 1999 Nov-Dec;17(6):699-704.

PMID:
10609068
[PubMed - indexed for MEDLINE]
20.

Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study.

Schoels M, Kapral T, Stamm T, Smolen JS, Aletaha D.

Ann Rheum Dis. 2007 Aug;66(8):1059-65. Epub 2007 Feb 16.

PMID:
17307765
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk